West Pharmaceutical Services, Inc.

    Jurisdiction
    United States
    LEI
    5493007NKRGM1RJQ1P16
    ISIN
    US9553061055 (WST)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    57 / 100
    Better than peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €105.22 117.3% overvalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Read full profile

    Fundamentals

    Net revenue
    €2.52B
    Gross margin
    35.3%
    EBIT
    €499.91M
    EBIT margin
    19.8%
    Net income
    €415.98M
    Net margin
    16.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.76B +9.2% €460.64M +10.7%
    €2.94B +6.7% €508.23M +10.3%
    €3.14B +6.6% €563.47M +10.9%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.22
    Ex date
    Payment date
    Dividend payout ratio
    12.3%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Lisa McClain August 13, 2025 $1.00K–$15.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K
    Robert Bresnahan May 8, 2025 $1.00K–$15.00K
    Robert Bresnahan March 27, 2025 $1.00K–$15.00K
    Jared Moskowitz March 6, 2025 $1.00K–$15.00K

    Earnings Calls

    Earnings Calls

    Latest earnings call: July 24, 2025 (Q2 2025)

    Add to watchlist

    Notifications